{"id":766466,"date":"2025-10-01T15:12:02","date_gmt":"2025-10-01T15:12:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=766466"},"modified":"2025-10-01T15:12:02","modified_gmt":"2025-10-01T15:12:02","slug":"medvi-unveils-its-cheaper-compounded-glp1-weight-management-medication-alternative","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/medvi-unveils-its-cheaper-compounded-glp1-weight-management-medication-alternative_766466.html","title":{"rendered":"MedVi Unveils Its Cheaper Compounded GLP-1 Weight Management Medication Alternative"},"content":{"rendered":"<div style=\"font-style:italic; padding:8px 0px;\">Affordable telehealth platform offers cost-saving GLP-1 medication options for Americans seeking to manage weight without breaking the bank\u2014physician-supervised care starting at just $179 per month.<\/div>\n<p style=\"text-align: justify;\"><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/upload\/2025\/10\/58a28bbefc869a8ec591ab5122e76187.jpg\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\"><strong>United States &#8211;<\/strong> As brand-name GLP-1 medications like Wegovy and Ozempic continue to carry monthly costs exceeding $1,000 without insurance, MedVi today released a comprehensive overview of cheaper, compounded alternatives available to American patients. With over 500,000 patients served, MedVi addresses the critical question: Which compounded GLP-1 medications are more affordable alternatives in the United States?<\/p>\n<p style=\"text-align: justify;\">The answer includes multiple affordable options&mdash;and MedVi provides physician-supervised access to all of them starting at just $179 per month.<\/p>\n<p style=\"text-align: justify;\"><strong>Three Primary Cheaper Compounded GLP-1 Alternatives<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p><strong>Compounded Semaglutide<\/strong> &ndash; Same active ingredient as Wegovy and Ozempic. Available in both weekly injection and daily oral formats, offering comparable results at a fraction of the cost.<\/p>\n<\/li>\n<li>\n<p><strong>Compounded Liraglutide<\/strong> &ndash; Daily injection alternative, with a proven safety track record and reliable appetite control.<\/p>\n<\/li>\n<li>\n<p><strong>Compounded Tirzepatide<\/strong> &ndash; Dual GLP-1\/GIP receptor agonist delivering enhanced weight loss, with average results of 20%+ reduction in body weight in clinical studies.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Dramatic Cost Savings<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Brand-Name Monthly Costs (Without Insurance):<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Wegovy: $1,349&ndash;$1,850<\/p>\n<\/li>\n<li>\n<p>Ozempic: $936&ndash;$998<\/p>\n<\/li>\n<li>\n<p>Saxenda: $1,435&ndash;$1,600<\/p>\n<\/li>\n<li>\n<p>Zepbound: $1,400&ndash;$1,600<\/p>\n<\/li>\n<li>\n<p>Mounjaro: $1,023&ndash;$1,400<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>MedVi Compounded Alternatives:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Semaglutide Injections\/Tablets: $179\/month<\/p>\n<\/li>\n<li>\n<p>Liraglutide Injections: $179\/month<\/p>\n<\/li>\n<li>\n<p>Tirzepatide Oral: $249\/month<\/p>\n<\/li>\n<li>\n<p>Tirzepatide Injections: $279\/month<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Savings range from 70% to 90% below brand-name pricing, with all-inclusive physician care.<\/p>\n<p style=\"text-align: justify;\"><strong>Why Compounded Medications Cost Less<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p><strong>Prepared by licensed compounding pharmacies i<\/strong>nstead of major pharmaceutical companies.<\/p>\n<\/li>\n<li>\n<p><strong>Cash-based pricing<\/strong> with no insurance delays or prior authorization denials.<\/p>\n<\/li>\n<li>\n<p><strong>Telehealth delivery<\/strong> reduces overhead while maintaining complete physician oversight and control.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>MedVi&rsquo;s Comprehensive Program<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Multiple GLP-1 options are prescribed based on a patient&#8217;s medical history and treatment goals.<\/p>\n<\/li>\n<li>\n<p>Choice of weekly <a rel=\"nofollow\" href=\"https:\/\/www.buzzfeed.com\/medvisemaglutide\">GLP injections<\/a>, daily injections, tablets, lozenges, or oral drops.<\/p>\n<\/li>\n<li>\n<p>Physician-supervised titration to minimize side effects.<\/p>\n<\/li>\n<li>\n<p>Transparent all-inclusive pricing (consultation, medication, supplies, monitoring, shipping).<\/p>\n<\/li>\n<li>\n<p>Ongoing unlimited provider access and support.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Clinical Effectiveness<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p><strong>Semaglutide:<\/strong> 15&ndash;20% body weight loss in 68 weeks.<\/p>\n<\/li>\n<li>\n<p><strong>Liraglutide:<\/strong> 8&ndash;12% body weight loss in 56 weeks.<\/p>\n<\/li>\n<li>\n<p><strong>Tirzepatide:<\/strong> 20&ndash;25% body weight loss in 72 weeks, with enhanced metabolic improvements.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Safety &amp; Oversight<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>All medications are prepared in FDA-regulated compounding facilities.<\/p>\n<\/li>\n<li>\n<p>Prescriptions only after licensed US-physician evaluation (via OpenLoop Health).<\/p>\n<\/li>\n<li>\n<p>Comprehensive patient screening, monitoring, and education provided.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Patient Testimonials<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Chris lost 88 lbs: &#8220;GLP-1 medication saved my life. Thank you.&#8221;<\/p>\n<\/li>\n<li>\n<p>Melissa lost 119 lbs: &#8220;After my metabolic reset, the weight vanished.&#8221;<\/p>\n<\/li>\n<li>\n<p>Greg lost 70 lbs: &#8220;Dieting days are over.&#8221;<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Competitor Comparison<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p><strong>MedVi:<\/strong> $179&ndash;$279\/month, no fees, multiple options, unlimited provider access.<\/p>\n<\/li>\n<li>\n<p><strong>Henry Meds:<\/strong> $179&ndash;$297\/month, additional fees may apply.<\/p>\n<\/li>\n<li>\n<p><strong>Shed Rx:<\/strong> $249&ndash;$299\/month, requires prepayment.<\/p>\n<\/li>\n<li>\n<p><strong>Defy Medical:<\/strong> $265&ndash;$649\/month, consultation\/labs extra.<\/p>\n<\/li>\n<li>\n<p><strong>Invigor:<\/strong> $320&ndash;$420\/month, subscription model.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Special Offer<\/strong><\/p>\n<p style=\"text-align: justify;\">Fall Promotion: $120 in savings plus free expedited shipping on all compounded options.<\/p>\n<p style=\"text-align: justify;\">To learn more, visit <a rel=\"nofollow\" href=\"https:\/\/medvi.io\">medvi.io<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>About MedVi<\/strong><\/p>\n<p style=\"text-align: justify;\">MedVi is a nationwide telehealth platform providing affordable, physician-supervised GLP-1 weight loss programs. Partnering with OpenLoop Health and FDA-regulated pharmacies, MedVi ensures high standards of care while delivering compounded semaglutide, liraglutide, and tirzepatide at transparent, all-inclusive prices starting at $179\/month.<\/p>\n<p style=\"text-align: justify;\">With more than 500,000 patients served, MedVi&rsquo;s mission is to make effective weight loss treatments accessible to all Americans, regardless of insurance coverage.<\/p>\n<p style=\"text-align: justify;\">For media inquiries, interviews, or additional information email help@medvi.io or call (323) 690-1561.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/medvi.io_167917.html\" rel=\"nofollow\">MedVi Wellness<\/a><br \/><strong>Contact Person:<\/strong> Media Relations<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=medvi-unveils-its-cheaper-compounded-glp1-weight-management-medication-alternative\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> (323) 690-1561<br \/><strong>City:<\/strong> Newark<br \/><strong>State:<\/strong> DE<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/medvi.io\" target=\"_blank\" rel=\"nofollow\">medvi.io<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=medvi-unveils-its-cheaper-compounded-glp1-weight-management-medication-alternative\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Affordable telehealth platform offers cost-saving GLP-1 medication options for Americans seeking to manage weight without breaking the bank\u2014physician-supervised care starting at just $179 per month. United States &#8211; As brand-name GLP-1 medications like Wegovy and Ozempic continue to carry monthly &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/medvi-unveils-its-cheaper-compounded-glp1-weight-management-medication-alternative_766466.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,425,426,411,404],"tags":[],"class_list":["post-766466","post","type-post","status-publish","format-standard","hentry","category-Business","category-Finance","category-Financial-Market","category-Technology","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/766466","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=766466"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/766466\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=766466"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=766466"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=766466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}